Similar articles

• Pathologic features of prostate cancer found at population-based screening with a four-year interval.

  Hoedemaeker RF, van der Kwast TH, Boer R, de Koning HJ, Roobol M, Vis AN, Schröder FH. Hoedemaeker RF, et al. J Natl Cancer Inst. 2001 Aug 1;93(15):1153-8. doi: 10.1093/jnci/93.15.1153. J Natl Cancer Inst. 2001. PMID: 11481387 Clinical Trial.
• [Clinical problems of systematic prostate needle biopsy in the detection of prostate cancer].

  Suzuki H. Suzuki H. Gan To Kagaku Ryoho. 2003 Jan;30(1):16-20. Gan To Kagaku Ryoho. 2003. PMID: 12557699 Japanese.
• Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?

  Mayes JM, Mouraviev V, Sun L, Tsivian M, Madden JF, Polascik TJ. Mayes JM, et al. Urol Oncol. 2011 Mar-Apr;29(2):166-70. doi: 10.1016/j.urolonc.2009.03.011. Epub 2009 May 17. Urol Oncol. 2011. PMID: 19451000
• Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancer.

  Fine SW, Reuter VE. Fine SW, et al. Histopathology. 2012 Jan;60(1):142-52. doi: 10.1111/j.1365-2559.2011.04004.x. Histopathology. 2012. PMID: 22212083 Review.
• Prostate biopsy 1999: strategies and significance of pathological findings.

  Iczkowski KA, Bostwick DG. Iczkowski KA, et al. Semin Urol Oncol. 1999 Nov;17(4):177-86. Semin Urol Oncol. 1999. PMID: 10632119 Review.